148 related articles for article (PubMed ID: 18167251)
1. [The clinico-pathological significance of protein expression of PAK1 in bladder transitional cell carcinoma].
Zhang YH; Xie D; Luo JH; Chen W; Chen LW; Xu QC; Liu GY; Ma HB; Lin WQ
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2710-3. PubMed ID: 18167251
[TBL] [Abstract][Full Text] [Related]
2. [The detection of protein expression of clusterin and Ki-67 and the status of cell apoptosis in bladder transitional cell carcinoma].
Chen W; Xie D; Luo JH; Wang CX; Tao Y; Zheng KL; Mei H
Zhonghua Wai Ke Za Zhi; 2006 Jan; 44(2):111-4. PubMed ID: 16620672
[TBL] [Abstract][Full Text] [Related]
3. [Clinicopathological significance of expression and amplification of P21-activated kinase 1 gene in colorectal carcinoma].
Li ZX; Zeng SD; Liu YD; Liao YJ; Hua WF; Lin F; Xie D
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Mar; 12(2):185-8. PubMed ID: 19296259
[TBL] [Abstract][Full Text] [Related]
4. [The clinical significance of expression and amplification of FGF3 in bladder transitional cell carcinoma].
Zhang YH; Xie D; Luo JH; Chen W; Chen LW; Xu QC
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(36):2556-9. PubMed ID: 17198565
[TBL] [Abstract][Full Text] [Related]
5. [Significance and mechanisms of overexpression of PAK1 gene in epithelial ovarian neoplasms].
Xie D; Yang GF; Chen YQ; Jiang LF; Xiao LZ
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):911-4. PubMed ID: 17533742
[TBL] [Abstract][Full Text] [Related]
6. [Expression of Caspase-3 and Bcl-2 in bladder transitional carcinoma and their significance].
Shen HW; Yi L; Wang XM; Yao MJ; Deng JW; Fang JZ; Li MN
Ai Zheng; 2004 Feb; 23(2):181-4. PubMed ID: 14960240
[TBL] [Abstract][Full Text] [Related]
7. [Expression of cyclooxygenase-2 in human transitional cell bladder carcinomas].
Zhan J; Tang XD
Ai Zheng; 2002 Nov; 21(11):1212-6. PubMed ID: 12526218
[TBL] [Abstract][Full Text] [Related]
8. Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: association with tumor progression.
King ED; Matteson J; Jacobs SC; Kyprianou N
J Urol; 1996 Jan; 155(1):316-20. PubMed ID: 7490878
[TBL] [Abstract][Full Text] [Related]
9. P21-activated kinase 1: a new molecular marker for intravesical recurrence after transurethral resection of bladder cancer.
Ito M; Nishiyama H; Kawanishi H; Matsui S; Guilford P; Reeve A; Ogawa O
J Urol; 2007 Sep; 178(3 Pt 1):1073-9. PubMed ID: 17644138
[TBL] [Abstract][Full Text] [Related]
10. [Expression of hypoxia inducible factor-1alpha and glucose transporter protein 1 in renal and bladder cancers and the clinical significance thereof].
Zhou JT; Cai ZM; Li NC; Na YQ
Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(28):1970-4. PubMed ID: 17064593
[TBL] [Abstract][Full Text] [Related]
11. [Smad4 and TGF-beta1 expression and clinical significance in bladder transitional cell carcinoma].
Tang ZY; Yang LY; Zhang YJ; Peng KL; Qi L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 31(3):363-6. PubMed ID: 16859125
[TBL] [Abstract][Full Text] [Related]
12. [Expression of cyclooxygenase-2 in bladder transitional cell carcinoma and the significance thereof].
Yu L; Chen XJ; Shi PQ; Ding Q; Sun CH; Liu GB; Shi DM; Huang YG
Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(38):2683-4. PubMed ID: 19080686
[TBL] [Abstract][Full Text] [Related]
13. [Expression of MUC1 and distribution of tumor-infiltrating dentritic cells in human bladder transitional cell carcinoma].
Xiang ST; Zhou SW; Guan W; Liu JH; Ye ZQ
Di Yi Jun Yi Da Xue Xue Bao; 2005 Sep; 25(9):1114-8. PubMed ID: 16174576
[TBL] [Abstract][Full Text] [Related]
14. [The mRNA expression of platelet-derived endothelial cell growth factor of bladder transitional cell carcinoma and its relation to invasiveness].
Li G; Zhang YF; Ding Q; Wen DG; Yan CY
Zhonghua Zhong Liu Za Zhi; 2004 Jan; 26(1):30-2. PubMed ID: 15059350
[TBL] [Abstract][Full Text] [Related]
15. [Correlation of clusterin expression to prognosis of bladder carcinoma].
Luo JH; Xie D; Chen W; Dai YP; Li XF; Tao Y; Zheng KL
Ai Zheng; 2005 Jun; 24(6):743-7. PubMed ID: 15946493
[TBL] [Abstract][Full Text] [Related]
16. CXCR4 expression in bladder transitional cell carcinoma and its relationship with clinicopathological features.
Li Y; Chen M; Yuan J; Zhou X; He W; Zu X; Qi L
Urol Int; 2014; 92(2):157-63. PubMed ID: 23988662
[TBL] [Abstract][Full Text] [Related]
17. [Expression of cyclooxygenase in bladder transitional cell carcinoma].
Wang KJ; Li H; Wei Q; Yang YR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 35(1):54-6. PubMed ID: 14981815
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of cell cycle biomarkers in nonmuscle invasive bladder transitional cell carcinoma.
Shariat SF; Ashfaq R; Sagalowsky AI; Lotan Y
J Urol; 2007 Feb; 177(2):481-7; discussion 487. PubMed ID: 17222615
[TBL] [Abstract][Full Text] [Related]
19. [Significance of activated matrix metalloproteinase 2 (MMP2) in progression of bladder transitional cell carcinoma].
Zhang XP; Zhou FJ; Shen PF; Zhou C; Wei JX
Ai Zheng; 2003 Jun; 22(6):637-9. PubMed ID: 12948424
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of fatty-acid synthase suppresses P-AKT and induces apoptosis in bladder cancer.
Jiang B; Li EH; Lu YY; Jiang Q; Cui D; Jing YF; Xia SJ
Urology; 2012 Aug; 80(2):484.e9-15. PubMed ID: 22554590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
